Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Sen Lin in Pharmaceutical Development
Introduction
Sen Lin is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory bowel disease. His innovative work has led to the development of a unique formulation that utilizes andrographolide, a compound known for its medicinal properties.
Latest Patents
Sen Lin holds a patent for the "Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereof." This invention focuses on the creation of an andrographolide enteric targeting micropellet and outlines the methods for its preparation. The patent emphasizes the therapeutic uses of andrographolide and its micropellets in developing effective treatments for inflammatory bowel disease. He has 1 patent to his name.
Career Highlights
Sen Lin is currently associated with Tasly Pharmaceutical Group Co., Ltd., a leading company in the pharmaceutical industry. His work at Tasly has allowed him to explore innovative solutions to complex health issues, contributing to the advancement of medical treatments.
Collaborations
Sen Lin collaborates with talented professionals in his field, including Henry Sun and Xiaohui Ma. These collaborations enhance the research and development efforts at Tasly Pharmaceutical Group, fostering an environment of innovation and creativity.
Conclusion
Sen Lin's contributions to pharmaceutical development, particularly through his patent on andrographolide formulations, highlight his role as an influential inventor in the industry. His work continues to pave the way for new treatments for inflammatory bowel disease, showcasing the importance of innovation in healthcare.